Product Information
AZITHROMYCIN 250 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2777 per EA under NDC 50111078710. Its NADAC has been published 432 times since Feb 28, 2018.
Strength
250 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
50111078710
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AZITHROMYCIN MONOHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA065225On Market Since
1/6/2006
Pharmacological Classes
Price Statistics
The NADAC for AZITHROMYCIN 250 MG TABLET has been published 432 times since Feb 28, 2018, and over the history we have for it it has declined 51.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2777 per EA |
|---|---|
| All-time high | $0.6928 (May 16, 2018) |
| All-time low | $0.2563 (Nov 20, 2024) |
| 52-week high | $0.3716 |
| 52-week low | $0.2777 |
| Median price | $0.4502 |
| Average price | $0.4573 |
| Largest weekly change | -35.6% (Nov 20, 2024) |
| Weeks tracked | 432 |
| Tracking since | Feb 28, 2018 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of AZITHROMYCIN 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AZITHROMYCIN 250 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.2777 per EA (NDC 50111078710), effective Jun 24, 2026.
How has the price of AZITHROMYCIN 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for AZITHROMYCIN 250 MG TABLET has declined 51.5%. It has been tracked across 432 weekly CMS publications since Feb 28, 2018.
What are the highest and lowest recorded NADAC prices for AZITHROMYCIN 250 MG TABLET?
Since Feb 28, 2018, the NADAC for AZITHROMYCIN 250 MG TABLET has ranged from a low of $0.2563 (Nov 20, 2024) to a high of $0.6928 (May 16, 2018), with a median of $0.4502 per EA.
Are there cheaper alternatives to AZITHROMYCIN 250 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as AZITHROMYCIN 250 MG TABLET, but none are currently priced below it.
Who manufactures AZITHROMYCIN 250 MG TABLET?
AZITHROMYCIN 250 MG TABLET (NDC 50111078710) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification